Similar title :
GBS by 7 % on plans for COVID-19 antibody studies after validation study
GBS Inc. share price gains on new SARS- CoV-2 Antibody Test
GBS Inc. Announces Plans for clinical SARS-CoV-2 antibody studies after the validation study

Ref: https://seekingalpha.com